.
1873 financial statements
* Numbers in millions
Year |
2019 | 2020 | TTM |
|---|---|---|---|
Capitalization * |
5 350 | 11 786 | 4 353 |
EV * |
4 495 | 12 447 | 12 447 |
Stock price ¤ |
3.82 | 7.5 | 2.77 |
Number of shares * |
1 400 | 1 572 | 1 572 |
EPS |
0,19 | -0,25 | -0,25 |
Revenue * |
323 | 697 | 697 |
Net income * |
266 | -387 | -387 |
Operating profit * |
44 | 125 | 125 |
Total liabilities * |
121 | 4 397 | 4 397 |
Net debt * |
-855 | 661 | 661 |
Total assets * |
1 899 | 8 154 | 8 154 |
Equity * |
1 777 | 3 757 | 3 757 |
Cash and investments * |
934 | 2 358 | 2 358 |
Over the past 10 years, the maximum capitalization of Viva Biotech Holdings is 11 786, the minimum is 5 350. Maximum net income 266, Minimum net income -387. The maximum price of 1873 shares is 7.5, the minimum price is 3.82.
.
1873 valuation
Year |
2019 | 2020 | TTM |
|---|---|---|---|
P/E |
20,12 | -30,47 | -11,25 |
P/B |
3,01 | 3,14 | 1,16 |
P/S |
16,56 | 16,91 | 6,25 |
E/P |
5% | -3% | -9% |
P/FCF |
-338,27 | -20,12 | -7,43 |
.
1873 profitability
Year |
2019 | 2020 | TTM |
|---|---|---|---|
ROE |
15% | -10% | |
ROA |
14% | -7% | |
ROIC |
2% | 2% |